etravirine 25 MG Oral Tablet [Intelence]

RxCUI: 1250723
RxNorm name: etravirine 25 MG Oral Tablet [Intelence]
Display name: etravirine 25 MG Oral Tablet [Intelence]
Full name: etravirine 25 MG Oral Tablet [Intelence]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Intelence	ETRAVIRINE	Janssen Products LP	6a9cbc29-9f15-4b24-8d86-206b82887f3d	2023-08-15	Warnings, Adverse reactions	Exact identifier rxcui: 1250723

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
6a9cbc29-9f15-4b24-8d86-206b82887f3d	etravirine 25 MG Oral Tablet [Intelence]	SBD	24	These highlights do not include all the information needed to use INTELENCE safely and effectively. See full prescribing information for INTELENCE. INTELENCE ® (etravirine) tablets, for oral use Initial U.S. Approval: 2008	20230815
6a9cbc29-9f15-4b24-8d86-206b82887f3d	Intelence 25 MG Oral Tablet	SY	24	These highlights do not include all the information needed to use INTELENCE safely and effectively. See full prescribing information for INTELENCE. INTELENCE ® (etravirine) tablets, for oral use Initial U.S. Approval: 2008	20230815
6a9cbc29-9f15-4b24-8d86-206b82887f3d	INTELENCE 25 MG Oral Tablet	PSN	24	These highlights do not include all the information needed to use INTELENCE safely and effectively. See full prescribing information for INTELENCE. INTELENCE ® (etravirine) tablets, for oral use Initial U.S. Approval: 2008	20230815